Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations

Chest

Volumn 118, Issue 1, 2000, Pages 123-128

  Okada, Morihito ^b   Tsubota, Noriaki ^a   Yoshimura, Masahiro ^b   Miyamoto, Yoshifumi ^b   Matsuoka, Hidehito ^b  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b NONE

Author keywords

Bulky N2 disease; Induction therapy; Lung cancer; Neoadjuvant therapy; Surgery

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

EID: 0033931213     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.1.123     Document Type: Article

References (30)

1. Patterson GA, Piazza O, Pearson FG, et al. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg 1987; 43:155-159
2. Daly BD, Mueller JD, Faling LJ, et al. N2 lung cancer: Outcome in patients with false-negative computerized tomographic scans of the chest. J Thorac Cardiovasc Surg 1993; 105:904-911
3. Mountain CF. Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer 1994; 73:2589-2598
4. Okada M, Tsubota N, Yoshimura M, et al. Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node which affects survival? J Thorac Cardiovasc Surg 1999; 118:270-275
5. Watanabe Y, Shimizu J, Oda M, et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg 1991; 51:253-261
6. Goldstraw P, Mannam GC, Kaplan DK, et al. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994; 107:19-28
7. Miller DL, McManus KG, Allen MS, et al. Results of surgical resection in patients with N2 non-small cell lung cancer. Ann Thorac Surg 1994; 57:1095-1101
8. Izbicki JR, Passlick B, Karg O, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995; 59:209-214
9. Okada M, Tsubota N, Yoshimura M, et al. Surgical approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg 1998; 115:836-840
10. Okada M, Tsubota N, Yoshimura M, et al. Extended sleeve lobectomy for lung cancer: The avoidance of pneumonectomy J Thorac Cardiovasc Surg 1999; 118:710-714
11. Okada M, Tsubota N, Yoshimura M, et al. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: Role of subcarinal node in selective dissection. J Thorac Cardiovasc Surg 1998; 116:949-953
12. Okada M, Tsubota N, Yoshimura M, et al. Role of pleural lavage cytology before resection for primary lung carcinomas. Ann Surg 1999; 229:579-584
13. World Heath Organization. Histologic typing of lung tumours. 2nd ed. Am J Clin Pathol 1982; 77:123-136
14. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
15. Naruke T, Suematsu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76:832-839
16. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481
17. Cox DW. Regression models and life tables. J R Stat Soc 1972; 34:187-220
18. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987; 67:1037-1049
19. Naruke T, Goya T, Tsuchiya R, et al. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 1988; 46:603-610
20. Thomas PH, Piantadosi S, Mountain CF. Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? J Thorac Cardiovasc Surg 1988; 95:883-887
21. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330:153-158
22. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA NSCLC. J Natl Cancer Inst 1994; 86:673-680
23. Sugarbaker DJ, Herndon J, Kohman LJ, et al. Results of cancer and leukemia group B protocol 8935. J Thorac Cardiovasc Surg 1995; 109:473-485
24. Mathisen DJ, Wain JC, Wright C, et al. Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1996; 111:123-133
25. Rapp E, Pater JL, Willon A, et al. Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer: Report of a Canadian multicenter randomized trial. J Clin Oncol 1988; 6:633-644
26. Bilfinger TV, Hartmann AR. Acute pulmonary failure with neoadjuvant protocol including mitomycin C and surgical therapy. J Thorac Cardiovasc Surg 1991; 102:935
27. Martini N, Flehinger BJ, Bains MS, et al. Management of stage III disease: Alternate approaches to the management of mediastinal adenopathy. In: Delarue NC, Eschapasse H, eds. Lung Cancer: International Trends in General Thoracic Surgery (Vol 1). Philadelphia, PA: WB Saunders, 1985; 108-120
28. Cybulsky IJ, Lanza LA, Ryan B, et al. Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg 1992; 54:533-537
29. Martini N, Kris MG, Flehinger BJ, et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993; 55:1365-1374
30. Okada M, Yamagishi H, Satake S, et al. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg 2000; 119:814-819